JAN 31, 2019 6:00 AM PST

Overcoming Challenges in EuCODE Cell Culture Platform Development

Presented at: BioProcessing 2019
Speaker
  • Principal Scientist, Ambrx
    Biography
      Weimin Lin earned a MD from Peking University Health Science Center which is the medical school of Peking University, and, a PhD from Georgia State University in cellular physiology program. After graduation, she joined Kinetic BioSystem Inc. and then KBI BioPharma which is a spin-out company of Kinetic Biosystems Inc., focusing on bioprocess development and clinical GMP manufacturing. In 2008, she joined Biogen cell culture development department pilot plant group and established small scale group in 2011 at RTP site. Currently, she is the principal scientist in cell culture development department at Ambrx. She leads the PD team to develop and optimize Ambrx unique EuCODE™ Cell Culture Platform including chemically-defined media, cell culture bioprocessing systems and biomanufacturing process modeling.

    Abstract

    Ambrx’s mammalian expression platform (EuCODE™) enables non-native amino acids (nnAAs) through an expanded genetic code to both generate novel bio-therapeutics and to optimize the performance of antibody drug conjugate (ADC), therapeutic proteins, monoclonal antibodies (mAbs), and, bi- and multi-specific medicines. While the ability to control the defined Drug-to-Antibody Ratio (DAR) and payload site can provide an advantage to an ADC, the site-specific incorporation of the nnAAs into the antibody heavy chain introduces a unique challenge for antibody production.

    To enable higher performance benchmarks in time and resources for process development with stringent product quality requirements, a proprietary cell culture platform is being developed and demonstrated fast-track development of high-quality, high-titer processes for producing recombinant proteins from CHO cells. 

    We successfully generated a CHO-K1 cell line, stably expressing engineered amber suppressor tRNA and its cognate tRNA synthetase specific for nnAA para-acetyl phenylalanine (pAF), to achieve high production of monoclonal antibodies (mAbs) containing nnAAs. The stable cell lines were further evolved using CRISPR/Cas9 genome editing technology to sequentially knock out selected genes in glutamine synthesis, and, apoptosis pathways to improve selection efficiency and prevent loss of viable cell mass in production cultures, respectively.  Inhibition of apoptosis pathway leads to dramatic increase in viable cell mass and results in extended production time and increased productivity. 

    In this presentation, we will discuss overcoming the challenges in cell culture platform development including cell line engineering, systematic DoE-based approaches on optimal chemically defined media and cell culture processes, and, strategies for scale up to clinical and commercial scales.

    Learning Objectives: 

    1. Learn what is cell culture platform and how to development your own cell culture platform
    2. Learn the strategy to develop your own chemically-defined media


    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
    MAR 16, 2021 10:00 AM PDT
    C.E. CREDITS
    MAR 16, 2021 10:00 AM PDT
    Date: March 16, 2021 Time: 10:00am (PST) Scientific progress and breakthroughs today are often too expensive for most institutions to acquire. Each year, the National Institutes of Health (N...
    DEC 15, 2020 10:00 AM PST
    C.E. CREDITS
    DEC 15, 2020 10:00 AM PST
    DATE: December 15, 2020 TIME: 10:00am PST Scientists from Thermo Fisher Scientific will walk us through the world of microorganisms. They will discuss their most recent research on viruses,...
    APR 01, 2021 8:00 AM PDT
    C.E. CREDITS
    APR 01, 2021 8:00 AM PDT
    Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
    JAN 31, 2019 6:00 AM PST

    Overcoming Challenges in EuCODE Cell Culture Platform Development

    Presented at: BioProcessing 2019

    Specialty

    Biochemistry

    Biotechnology

    Microbiology

    Molecular Biology

    Cell

    Research

    Bioproduction

    Immunity

    Bioprocess

    Disease

    Laboratory Testing

    Neuroscience

    Cell Culture

    Chemistry

    Protein

    Geography

    North America50%

    Asia33%

    Europe17%

    Registration Source

    Website Visitors100%

    Job Title

    Student33%

    Medical Doctor/Specialist17%

    Medical Laboratory Technician17%

    Scientist17%

    Lab Management17%

    Organization

    Academic Institution50%

    Clinical Laboratory17%

    Biotech Company17%

    Manufacturer - Other17%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more